“shire” Archives

in
Entry Author Date Location
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
With New Name and $47M, Proclara Begins First Big Alzheimer’s Test 09/07/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy 07/28/16 National
Merck, Amgen Invest in Akili as Therapeutic Video Game Moves Ahead 07/20/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree 03/22/16 New York
Armed With $30M, Akili Plans Bigger Trial of Therapeutic Video Game 01/22/16 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Still Eyeing Baxalta, Shire Pulls Trigger on $6.5B Dyax Buyout 11/02/15 Boston
Amid Nobel Prize Suspense, Making Sense Of Latest Gene-Editing News 10/06/15 National
West Coast Biotech Roundup: Amgen, Grizzlies, Topol, Faraday & More 09/03/15 San Francisco
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug 08/31/15 Boston
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher 08/31/15 New York
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal 08/03/15 New York
Alexion Shells Out $8.4B for Synageva In Rare Disease Mega-Deal 05/06/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More 02/26/15 San Francisco
Shire Acquires Meritage Pharma in Deal Potentially Worth $245M 02/24/15 San Diego
Valeant to Acquire Specialty Pharma Salix in $14.5B Deal 02/22/15 Raleigh Durham
Report: Troubled Salix Emerges as Valeant’s Latest Takeover Target 02/03/15 Raleigh Durham
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Page 1 of 5 next page »